Protagonist Therapeutics
PTGX
$26.09
Share price
2.15%
Change (1 day)
10.55%
Change (1 year)
Categories
Protagonist Therapeutics (PTGX) - P/B ratio
P/B ratio as of May 2024 : 4.45
According to Protagonist Therapeutics
's latest financial reports the company has a price-to-book ratio of 4.45.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Protagonist Therapeutics - P/B ratio (from 2016 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.93 | 57.79% |
| 2022-12-31 | 2.49 | -54.24% |
| 2021-12-31 | 5.44 | 75.41% |
| 2020-12-31 | 3.10 | 29.26% |
| 2019-12-31 | 2.40 | 73.02% |
| 2018-12-31 | 1.39 | -61.71% |
| 2017-12-31 | 3.62 | -13.71% |
| 2016-12-31 | 4.20 | |
| 2015-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | -35.61% | 🇺🇸 USA |